L-Citrulline (and Why Not L-Arginine)

Supplements · §513

A tart powder in a glass of water once a day, for roughly fifty dollars a year, that nudges your resting blood pressure down a few points and — in the half of mild-ED men who respond — quietly brings the morning erection back inside a month. It also makes the second-to-last set of bench press a little less brutal and the next day's soreness a little less stubborn. None of these wins is transformative; all of them are real and cheaply earned. The catch worth saying up front: it is L-citrulline, not L-arginine, that you actually want — and despite what most of the supplement aisle suggests, the difference is settled biochemistry, not marketing.

Do · Daily Evidence Emerging Chapter Supplements

The strongest signal is the blood-pressure one — small, steady, and replicated in meta-analysis. The most personally felt one is the mild-ED recovery rate, which lands inside a month at a dose that fits in two capsules. The gym effects are real but modest; if you're already on creatine and caffeine, this is the small extra rep, not the new training stimulus. Three to six grams of L-citrulline a day, the same dose used in nearly every positive trial, runs about fifty dollars a year. You have to actually take it daily for the blood-pressure and erection effects to hold.

Your blood vessels relax when their inner lining releases a small gas called nitric oxide. That signal tells the surrounding muscle to loosen, which widens the vessel, drops the pressure inside it, and lets more blood through. Erections, the pump in your forearms during a heavy set, the way your legs feel on a long climb — they all run through the same chemistry. The body makes nitric oxide from an amino acid called arginine. The shortcut most supplement labels sell you is "take more arginine." The shortcut that actually works is "take citrulline" — because your gut and liver chew up most of the arginine you swallow before it ever reaches the bloodstream, while citrulline slips through and gets turned into arginine inside the kidneys Schwedhelm et al. 2008. Three grams of citrulline raises the arginine in your blood more reliably than three grams of arginine does, and the effect lasts longer.

There is a wrinkle worth knowing — what researchers call the arginine paradox. In a healthy young adult with a normally functioning vessel lining, the raw materials for nitric oxide are already plentiful, and adding more should change nothing. It changes nothing in that person. In the reader whose vessels are stiffening with age, or whose blood pressure is creeping up, or whose erections are quietly fading, there is a competing molecule called ADMA that blocks the nitric-oxide enzyme, and the extra arginine outcompetes it. That is why this supplement does the most for the people who most want it to.

What the trials actually show

Three independent strands of evidence converge, each modest on its own and all of them in the same direction.

On blood pressure, the cleanest answer comes from a pooled analysis of eight randomised trials: three to six grams a day of L-citrulline drops resting systolic pressure by around four points, with the biggest movers being the people who already had elevated pressure to begin with Mahboobi et al. 2019. Four millimetres of mercury is not the kind of change you feel — but at the population scale it is the kind of change that maps onto fewer heart attacks and strokes over decades.

On exercise, the picture is "real but small." A 2019 meta-analysis pooled twelve trials of acute pre-workout citrulline against placebo on high-intensity strength and power; the effect was statistically significant but the size was modest — the kind of edge a population sees on average and any individual lifter might or might not notice Trexler et al. 2019. A separate meta-analysis found citrulline reliably lowers how hard the work feels after a session, even when it doesn't reliably change next-day soreness or lactate Rhim et al. 2020. So: the work feels a little easier, you might get an extra rep on the back half of a heavy set, and the pump in the mirror is real. Don't expect this to be your training breakthrough.

How to take it

The doses that worked in the trials are not the ones on most pre-workout labels. Buy plain L-citrulline powder in bulk — not arginine, not a "nitric oxide complex," not a one-gram capsule in a multi-ingredient blend.

The blood-pressure and erection effects are accrued: they need a week or two of consistent daily dosing to settle in and they fade out if you stop. The workout effect is acute — if you take it pre-workout, you take it pre-workout. Most readers find the cheapest practical setup is a bag of plain citrulline powder in the kitchen and one scoop in a glass of water with breakfast. The taste is mildly tart; mixing it into coffee, juice, or any flavoured drink hides it completely.

Who actually responds

The arginine paradox cuts both ways: the people whose vessels are already working perfectly are the people for whom this does the least. A healthy twenty-five-year-old with normal blood pressure, normal erections, and no athletic complaints can take citrulline for a year and notice nothing. Don't take that as failure — there was nothing for it to fix.

The three populations who get the most out of it:

Anyone with a creeping cuff reading. If your doctor has said "high-normal" or "borderline" at the last two physicals, you are exactly the person the meta-analysis was about. Stack it with the rest of what works — weight, walking, sleep, alcohol restraint — and it adds a few points more.
Men in their forties and beyond noticing erections aren't what they were. Mild — meaning still mostly works, but less reliable, softer, slower to come back — is the population Cormio studied. Severe or sudden ED is a different conversation: it's a cardiovascular warning sign and belongs in a clinician's office, not a supplement shelf.
Trainees doing high-volume resistance work or hard intervals. The effect is incremental on top of creatine and caffeine, not a replacement for either.

What most guides get wrong

"Take L-arginine." The supplement aisle still sells more arginine than citrulline, and at higher prices per gram. The bioavailability data have been clear for over fifteen years: gram for gram, citrulline raises plasma arginine more than arginine itself does Schwedhelm et al. 2008. Pick citrulline.

"The pump is the point." The vasodilatory pump in the mirror is real and measurable, but it isn't the muscle-growth signal. The defensible workout claim is the extra rep on the back-half of a hard set — the volume that the pump is a side-effect of, not a cause of.

"It works like Viagra." It acts on the same pathway, but the effect is a fraction of the size. PDE5 inhibitors (sildenafil, tadalafil) are the right tool for moderate or severe erectile dysfunction. Citrulline lives in the mild end of the spectrum, where a daily supplement can be enough on its own.

"More is better." Above roughly ten grams a day, the only thing most people get extra is loose stool. The trial doses — three to six grams — are where the evidence is.

When not to take it

You are on nitrate drugs (nitroglycerin, isosorbide) for chest pain. Citrulline and nitrates both crank up the same vasodilation pathway; stacking them risks symptomatic low blood pressure. Talk to your cardiologist before adding it.
You take Viagra or Cialis. Same pathway, downstream. A combination isn't dangerous for most healthy men, but the additive vasodilation can produce dizziness on standing — and if you're on these drugs because of cardiovascular disease, the precaution above applies.
You have recently had a heart attack. A clinical trial of high-dose L-arginine started within weeks of a heart attack was stopped early because the arginine arm had more deaths than placebo Schulman et al. 2006. This was at nine grams a day of arginine, not citrulline, and the population was acutely sick — but the signal draws a hard line: the months after a cardiac event are not the time to start NO-boosting supplements without your cardiologist's sign-off.
You have advanced kidney disease. The kidneys are where citrulline gets converted to arginine; a high amino-acid load is conventionally avoided in advanced CKD. Check with your nephrologist.
You have frequent herpes outbreaks. Arginine is a building block the virus uses to replicate, and some readers with frequent outbreaks report worsening on supplementation. The clinical data are thin, but the cost of switching to dietary nitrate instead — beetroot, leafy greens — is also thin.

What changes, and when

Inside a week: if you train, the pump in the mirror at the end of a session is a touch bigger and the second-to-last set goes a rep or two further than you remember Pérez-Guisado and Jakeman 2010. The work feels marginally easier — the rating-of-perceived-exertion effect is the most robust performance signal in the literature Rhim et al. 2020. No one but you is going to notice this.

Inside three to six weeks: if you're measuring blood pressure at home — and you should be, if it's been creeping up — the systolic number is two to five points lower than your baseline range Mahboobi et al. 2019. You will not feel this. The cuff will show it.

Inside a month, for the mild-ED responder: morning erections that had been quietly fading come back, not every morning, but more often than not Cormio et al. 2011. Your partner notices before you bring it up. The Friday night that had started to feel like a forecast stops being a forecast. About half of men in the mild-ED population respond inside the month; the other half don't, and the honest move is to stop and try something else.

Over years: the same vessel-lining effect that drops the cuff number a few points also softens the slow background story of skin and scalp blood flow — not the reason to take this, but a quiet downstream of cleaner vascular health. Don't expect a mirror difference.

What you do not get: a transformed cognitive day, a new energy floor, a fundamentally different body. This is the cheap, narrow, daily win — and for the people it works for, the narrow win is worth the tart powder in the glass.

Related, worth a look

Dietary nitrate — beetroot juice and leafy greens hit the same nitric-oxide pathway through a different route (the bacteria on your tongue convert nitrate to nitrite, which becomes NO). Comparable or larger acute effect on blood pressure and exercise tolerance. Often stacks cleanly with citrulline.
Creatine. Larger effect on strength and on the same training population. If you only take one supplement for the gym, take creatine.
The full mild-ED workup. Erections that are fading are also a vascular signal; cuff readings, body weight, sleep quality, alcohol intake, and a basic cardiovascular check belong in the same conversation as a supplement.

Substance + claimed effects

L-arginine and L-citrulline are two non-essential amino acids that share a single biochemical job for the cardiovascular consumer: they raise plasma arginine, the substrate that endothelial nitric oxide synthase (eNOS) converts into nitric oxide (NO), which dilates blood vessels. Arginine is the direct substrate; citrulline is its longer-lasting precursor — counterintuitively, oral citrulline raises plasma arginine more reliably than oral arginine itself, because arginine is heavily catabolised on first pass by intestinal and hepatic arginase while citrulline bypasses that and is converted to arginine in the kidneys Schwedhelm et al. 2008. The catalogue treats them as one entry because the downstream pharmacology is the same NO-availability story; the practical recommendation just lands on citrulline. Claimed consequences this entry covers: modest reductions in resting blood pressure, improved exercise tolerance and reduced muscle soreness at supraphysiological doses, recovery of erection hardness in mild erectile dysfunction, and post-exercise blood-flow / pump effects. The corresponding meta dimensions in scope are health_short_term, energy, mood (the ED-recovery payoff), longevity (downstream of the BP effect), and beauty_cumulative (downstream of endothelial health). Cognitive, sleep, and direct skin effects are not claimed and score zero.

Evidence by addressing question

mechanism

Endothelial NO is produced from L-arginine and molecular oxygen by eNOS. NO diffuses into vascular smooth muscle, activates soluble guanylate cyclase, raises cGMP, and relaxes the vessel — the same final pathway PDE5 inhibitors (sildenafil) act on downstream Bode-Böger et al. 2007. The naive prediction — "give arginine, raise NO" — fails because plasma arginine in healthy adults is already well above the K_m of eNOS, so adding more substrate should not change flux. This is the "arginine paradox": clinical effects of arginine supplementation are real, but they cannot be explained by simple substrate kinetics. The leading explanation is that exogenous arginine competes with asymmetric dimethylarginine (ADMA), an endogenous eNOS inhibitor, restoring the arginine/ADMA ratio in conditions where ADMA is elevated (aging, hypertension, hypercholesterolaemia, diabetes) Bode-Böger et al. 2007. Citrulline's mechanistic advantage is pharmacokinetic: 3 g of oral citrulline raises plasma arginine more, and for longer, than 3 g of oral arginine, because citrulline escapes splanchnic arginase and is recycled into arginine in the proximal tubule of the kidney Schwedhelm et al. 2008. Citrulline malate — the form used in most exercise trials — pairs citrulline with malate, a Krebs-cycle intermediate; the malate component is sometimes invoked to explain ergogenic effects, though its independent contribution is not well characterised Trexler et al. 2019.

evidence

Blood pressure. A 2019 meta-analysis of 8 RCTs (n=372) found L-citrulline supplementation lowered systolic BP by a pooled −4.10 mmHg (95% CI −7.94 to −0.27) and diastolic BP by −2.08 mmHg (95% CI −4.32 to 0.16), with the effect most pronounced in hypertensive subgroups Mahboobi et al. 2019. A separate Nutrients review covering both arginine and citrulline trials reached compatible conclusions: doses of 3–6 g/day citrulline or 6–10 g/day arginine produce small but consistent reductions in systolic BP, with larger effects in baseline hypertension Khalaf et al. 2019. The Allerton 2018 cardiometabolic review documents the same direction of effect and adds endothelial-function (flow-mediated dilation) improvements as a secondary endpoint Allerton et al. 2018.

Exercise performance — endurance. Bailey 2015 ran a randomised crossover trial: 6 g/day L-citrulline for 7 days improved O₂ uptake kinetics during severe-intensity cycling and increased time to exhaustion in a 16.2 km TT by ~1.5% versus placebo Bailey et al. 2015. Figueroa 2017 reviewed citrulline and watermelon (a citrulline source) trials and concluded the endurance signal is real but small, and most robust at doses ≥6 g taken for at least a week rather than acutely Figueroa et al. 2017.

Exercise performance — strength. Pérez-Guisado 2010 reported an oft-cited acute effect of 8 g citrulline malate taken 1 hour pre-workout: trained men completed ~52% more reps on the second through seventh sets of barbell bench press at 80% 1RM, with a ~40% reduction in 24- and 48-hour soreness Pérez-Guisado and Jakeman 2010. Wax 2015 replicated a smaller but directionally consistent effect in advanced weightlifters using leg press, hack squat, and leg extension to failure Wax et al. 2015. The 2019 Sports Medicine meta-analysis (Trexler et al.) pooled 12 trials and reported a small but statistically significant ergogenic effect on high-intensity strength/power performance, with an effect size of 0.20 (95% CI 0.06–0.34) — meaningful at the population level, individually undetectable for many trainees, and heterogeneous across trial designs Trexler et al. 2019.

Exercise performance — soreness and RPE. Rhim 2020 meta-analysed 13 RCTs on post-exercise rating of perceived exertion (RPE), muscle soreness, and blood lactate. Citrulline reduced post-exercise RPE (standardised mean difference −1.10, p=0.04) but did not significantly affect soreness or lactate, suggesting the felt-easier effect is real where the objective tissue-damage and metabolic-byproduct effects are not Rhim et al. 2020.

Erectile function. Cormio 2011 ran a single-blind crossover trial in 24 men with mild ED: 1.5 g/day oral L-citrulline for 1 month improved erection hardness score from 3 (mild ED) to 4 (normal) in 50% of treated patients vs 8.3% on placebo — a small but cleanly reported effect at a dose that is trivial to take Cormio et al. 2011. Stanislavov 2003 reported L-arginine 1.7 g/day combined with pycnogenol (pine bark extract) restored erectile function in ~92% of men with ED over 3 months, but the design is open-label and the combination doesn't isolate arginine's contribution Stanislavov and Nikolova 2003. The effect size in Cormio is smaller than PDE5 inhibitors but the safety and access profile is different — a daily supplement vs a prescription drug.

Vascular function in older adults. Gonzales 2017 measured exercise-induced femoral blood flow in older adults (60–75 y) before and after 14 days of 6 g/day L-citrulline. Resting brachial pulse wave velocity decreased modestly; the exercise-blood-flow signal was null on the primary endpoint but trended in the expected direction, with the authors noting the population already had relatively preserved vascular function Gonzales et al. 2017.

Acute MI — the cautionary trial. Schulman 2006 (VINTAGE MI) randomised 153 patients after acute myocardial infarction to 9 g/day L-arginine vs placebo on top of standard care. The trial was halted early: 6 deaths in the arginine arm vs 0 in placebo over 6 months, with no improvement in vascular stiffness or LV function Schulman et al. 2006. This does not generalise to healthy supplemental users at lower doses, but it draws a hard line against high-dose arginine in the post-MI window.

protocol

Practical dosing converges across the endpoints: L-citrulline 3–6 g/day, taken either daily or 30–90 minutes pre-exercise, is the dose that appears in nearly every positive RCT covering BP, endothelial function, and endurance Mahboobi et al. 2019 Bailey et al. 2015. For acute strength/pump effects, the citrulline-malate trials used 8 g (containing ~4.5 g citrulline) taken 60 min pre-workout Pérez-Guisado and Jakeman 2010. For mild ED, 1.5 g/day citrulline is sufficient per Cormio Cormio et al. 2011. For arginine, equivalent NO effects require roughly 2–3× the dose because of first-pass loss — 6–10 g/day is the studied range Khalaf et al. 2019 — but citrulline at lower doses produces higher steady-state plasma arginine than arginine at higher doses Schwedhelm et al. 2008, which is why the practical recommendation collapses to citrulline.

contraindications

Two real concerns and several minor ones. Nitrates (nitroglycerin, isosorbide) and PDE5 inhibitors (sildenafil, tadalafil) act on the same NO/cGMP pathway downstream; combining either with high-dose arginine or citrulline can produce additive vasodilation and symptomatic hypotension. Recent myocardial infarction — the VINTAGE MI signal of increased mortality on 9 g/day arginine post-MI is the hard line Schulman et al. 2006; this maps to the cardiac-condition contraindication token. Severe kidney disease — citrulline-to-arginine conversion happens in the proximal tubule, and high amino-acid loads in advanced CKD are conventionally avoided; map to kidney-disease. Herpes simplex — arginine is a substrate for HSV replication in cell-culture studies and frequent-outbreak patients sometimes anecdotally report exacerbation, though clinical evidence is thin. Pregnancy — no clear safety signal but no positive evidence either; default to clinician input. GI side effects (loose stool) are dose-dependent and trivial below ~10 g.

misconceptions

Three high-volume ones. "L-arginine is the active ingredient, so take L-arginine." Plasma kinetics dispute this: oral citrulline raises arginine availability more than oral arginine Schwedhelm et al. 2008. The supplement industry continues to sell arginine at higher prices because the legacy formulation predates the citrulline literature. "More pump = more growth." The vasodilatory pump is real and measurable but is not the same construct as hypertrophic stimulus; the rep-volume increase in the strength trials is the mechanistically defensible ergogenic claim, not the pump per se. "It works like Viagra." It acts on the same pathway but at a fraction of the effect size; PDE5 inhibitors remain the first-line pharmacotherapy for moderate-to-severe ED. Citrulline is a daily-supplement intervention for the mild end of the spectrum and a possible adjunct elsewhere.

audience

Highest expected response in three subgroups. Adults with elevated BP (140/90 and the high-normal range) — the Mahboobi meta showed the largest deltas in hypertensive subgroups Mahboobi et al. 2019. Men with mild ED — Cormio's 1.5 g/day, 50% responder rate population is exactly the morning-erection-fading midlife reader Cormio et al. 2011. Endurance and resistance trainees running supraphysiological pre-workout doses for pump and rep tolerance Trexler et al. 2019 Bailey et al. 2015. Note that healthy young men with intact endothelial function and unrestricted dietary arginine have the smallest response — the arginine paradox cuts both ways.

alternatives

For NO availability: dietary nitrate (beetroot juice, leafy greens) acts via a parallel pathway (nitrate → nitrite → NO via the entero-salivary circulation), with a comparable or larger acute BP and exercise-tolerance literature. For BP specifically: the standard pharmacologic and lifestyle ladder (DASH diet, exercise, weight loss, antihypertensives) dwarfs citrulline's effect. For mild ED: weight loss, exercise, sleep apnea screening, testosterone evaluation if indicated, and PDE5 inhibitors as needed — citrulline sits below all of these for severity-of-ED above mild. For acute pump/strength: caffeine and creatine have larger ergogenic effects and stronger evidence; citrulline is additive, not competitive.

failure-modes

The most common is dosing too low: 1 g/day capsules from a multi-ingredient pre-workout don't reach the studied range. The second is sourcing arginine instead of citrulline at equivalent doses — the gram-for-gram comparison goes to citrulline on bioavailability. The third is expecting an acute felt effect on the first dose; BP and endothelial-function effects are subclinical and accrue over a week or more Bailey et al. 2015. The fourth is taking it with nitrates, which produces dizziness on standing.

practicalities

Bulk citrulline malate or pure L-citrulline powder runs roughly $20–40 for a 90–180 day supply at 6 g/day from major supplement retailers (2024 prices), putting yearly cost in the trivially-low band. Taste is mildly tart (especially the malate); most users dissolve it in water or stack it into a pre-workout shake. Tablets and capsules at studied doses run materially more expensive per gram but are practical for daily-low-dose ED use (1.5 g/day = a single scoop or two capsules). No prescription required in most jurisdictions; sold as a dietary supplement under DSHEA in the US, falling outside FDA pre-market approval.

stakes

Stakes-of-absence are modest and mostly indirect: the entry is a small-magnitude lever stacked on top of the larger BP and ED interventions. The honest framing is opportunity cost — a cheap, low-effort lever that produces small but reliable gains on three dimensions men in their 40s–60s actively want (BP, sex, exercise tolerance) is the kind of thing whose absence is not catastrophic but whose presence rounds the catalogue up.

payoff

Felt-experience layer: a week of 6 g citrulline lifts the pump in the gym in a way most trainees notice subjectively, even where the rep-count delta in trials is small Pérez-Guisado and Jakeman 2010. A month at 1.5 g/day in a mild-ED responder restores morning erections in roughly half of men Cormio et al. 2011. Resting BP drops a few mmHg over weeks — invisible day-to-day, real on the cuff Mahboobi et al. 2019. None of this is transformative; all of it is real.

The credibility range

Optimist case

Citrulline is a rare supplement with consistent positive meta-analyses across three independent endpoints (BP, ED, exercise) at safe doses, in a mechanism that biology clearly understands (NO availability), at a yearly cost trivial enough that the burden-side veto doesn't fire. For the mild-ED responder in the Cormio population, the win is not subtle — 50% of treated men moved from mild ED to normal erection hardness in a month at 1.5 g/day Cormio et al. 2011. For the BP-elevated 50-year-old, the cuff shifts a few mmHg downward, and small population BP shifts map to meaningful cardiovascular-event reductions at the cohort scale Mahboobi et al. 2019. The bioavailability advantage over arginine is a clean pharmacokinetic story Schwedhelm et al. 2008, and the safety profile across thousands of subject-weeks is benign. The optimist's bet: this is one of the cleanest cost-effectiveness wins in the supplement aisle.

Skeptic case

Effect sizes are small. The Trexler meta found d=0.20 on high-intensity strength/power — at the edge of detection, with substantial heterogeneity across trials Trexler et al. 2019. The Mahboobi systolic BP delta of −4 mmHg sits in the same range as the placebo response in many BP trials, and the confidence interval grazes zero on diastolic Mahboobi et al. 2019. Most positive ED trials are small (Cormio n=24) and the larger combination trial (Stanislavov) is open-label with a confounding co-intervention Stanislavov and Nikolova 2003. The VINTAGE MI mortality signal is a real reminder that the arginine/NO story has clinical surprises in unhealthy vascular beds Schulman et al. 2006. The skeptic's bet: small effect, publication-biased literature, a real but modest tool that the wellness industry has hyperbolised.

Author's call

Lands optimist-leaning but small-effect-honest. The evidence converges on a low-cost, low-risk supplement that produces measurable, modest improvements in BP, ED responsiveness in mild cases, and exercise feel — not a transformative supplement. The right framing for the article is "an honest small win," not "a breakthrough." Evidence score should reflect that multiple meta-analyses converge but effect sizes are modest; controversy is low (the field broadly agrees on both the direction and the magnitude). Daily 3–6 g L-citrulline is the protocol that maps to the trial literature.

Stakeholder + incentive map

Supplement industry — citrulline malate is a margin-positive ingredient that ships in nearly every pre-workout product; manufacturers benefit from hype around pump and performance and tend to under-emphasise the modest effect-size literature.
Sports nutrition research community — citrulline malate has been a productive grant area; positive trials get published faster than null ones (the usual publication-bias caveat applies, though the meta-analyses attempt correction).
Urology / men's-health clinics — supplement-stack recommendations including citrulline for mild ED are common in cash-pay men's-health practice; the Cormio finding gives it cover.
Pharmaceutical interests — PDE5 inhibitor manufacturers (Pfizer, Lilly) have no incentive to amplify citrulline, but the effect sizes are different enough that direct competition is limited.
Mainstream cardiology — citrulline doesn't appear in hypertension guidelines (USPSTF, AHA/ACC) because the effect size is below the threshold for clinical recommendation; this is a fair reading, not negligence.

Population variability

Response is largest in the populations with baseline endothelial dysfunction: hypertensives, mild-ED midlife men, older adults with elevated ADMA. Response is smallest in healthy young men with normal endothelial function — the arginine paradox predicts this, and the trial literature confirms it. The Cormio ED population was specifically mild ED (erection hardness score 3); the responder rate would be lower in moderate or severe ED, where PDE5 inhibitors are the appropriate first line. The exercise effect generalises across resistance-trained men, with thinner evidence in women and untrained subjects. Citrulline appears safe across the population spread tested in the trials (~18–75); no signal in pregnant women has been tested and that population is excluded by default. Vegetarian/vegan diets are arginine-replete (legumes, nuts, seeds) and may show smaller relative responses to supplementation.

Knowledge gaps

Long-term (>12 month) RCTs are absent; we don't know whether the BP effect sustains, attenuates with tachyphylaxis, or compounds.
The arginine paradox is the leading mechanistic explanation but the relative contributions of ADMA competition, substrate provision, and NO-independent pathways are not cleanly separated.
The malate component of citrulline malate has not been isolated against pure citrulline at matched citrulline doses in well-powered trials; the ergogenic literature conflates the two forms.
Female-specific data are thin across all three endpoints.
No mortality endpoint trial in supplemental users; the only mortality signal is the VINTAGE MI safety alarm in a different population Schulman et al. 2006.
Interaction studies with antihypertensives are limited; the additive-vasodilation concern is mechanism-derived more than trial-derived.

Title framing. Brief named L-Arginine and Citrulline; entry covers both holistically but recommends citrulline. Title leads with the recommendation rather than reading like a comparison piece — the misconceptions section carries the arginine-vs-citrulline correction without the title having to.

Coverage relative to brief. The brief named blood flow, blood pressure, exercise performance, erectile function, and recovery. The article covers all five: BP and erectile function in evidence + payoff, exercise performance + recovery (soreness, RPE) in evidence + payoff, blood flow as the mechanism that unifies them. Vascular support is the through-line, not its own section.

Hard scoping calls.

Excluded sickle-cell disease, pulmonary hypertension, intermittent claudication, and the diabetes endothelial-function literature. These are clinical indications, not consumer supplement use, and each warrants a clinician relationship rather than a daily-powder protocol.
Excluded the growth-hormone-secretion arginine literature. The acute GH spike from arginine bolus is real but the downstream physiological consequence in adults is negligible — including it would inflate the felt-effect implication beyond the evidence.
Excluded ornithine (the third urea-cycle amino acid sometimes sold alongside arginine) — bioavailability and effect evidence is thinner; not enough material for its own entry yet.

Rating difficulties. longevity was the hardest call. The BP delta from Mahboobi maps to small mortality reductions at the population scale, but no direct mortality RCT in supplemental users exists and the VINTAGE MI signal explicitly caps the upside in post-MI populations. Landed on 1 (marginal contribution). mood is 1 on the indirect ED-recovery pathway, not on direct mood evidence — flagged so a reviewer doesn't expect a mood RCT to anchor it.

Dream narrative call. Overall score lands at roughly 20 — below the obligatory threshold of 40. Wrote a narrative anyway because the mild-ED responder population is a real relief-lever cascade the entry can honestly project; without it, the tagline would have been a flatter "modest supplement, modest effects" register that under-sells the responder cohort. The dream narrative is the relief lever per dream-narrative.md §3, not aspiration.

Future links to wire when they exist: dietary nitrate / beetroot, PDE5 inhibitors (decide-tier entry), home blood-pressure monitoring (test-tier), and creatine. related deliberately left unset — none of these exist in the catalogue yet at write time.

Audience scoping not used. Considered scoping the entry male-only because the ED evidence is male-specific and the strongest payoff cited is male. Rejected: BP and exercise benefits apply equally to women, and the male-only literature gap on the cardiometabolic side is a publication-bias artefact, not a biology one. The article's audience section names the male population explicitly where it matters; meta-level scoping would have over-narrowed reach.

Contraindications used: cardiac-condition (nitrate interaction + VINTAGE MI), kidney-disease (citrulline-to-arginine conversion site). Did not use blood-thinners — no direct interaction signal; arginine/citrulline don't act on coagulation in a way that would amplify warfarin or DOACs at supplemental doses.